Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey N Martin

Showing results (11-20 of 358) with videos related to

Pageof 36
Sort By:
AIDS (London, England)|September 9, 2004
Isolated lopinavir resistance after virological rebound of a ritonavir/lopinavir-based regimenJohn Friend, Neil Parkin, Teri Liegler, et al.
AIDS (London, England)|January 25, 2002
Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremiaSteven G Deeks, Jason D Barbour, Robert M Grant, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2009
Use of saliva as a lubricant in anal sexual practices among homosexual menLisa M Butler, Dennis H Osmond, Alison Graves Jones, et al.
Journal of Clinical Epidemiology|July 28, 2023
Key concepts in clinical epidemiology: collider-conditioning biasJean C Digitale, Jeffrey N Martin, David V Glidden, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2002
Effect of long-term highly active antiretroviral therapy in restoring HIV-induced abnormal B-lymphocyte functionMark A Jacobson, Hassan Khayam-Bashi, Jeffrey N Martin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
HIV-induced changes in T cell signaling pathwaysMarc Schweneker, David Favre, Jeffrey N Martin, et al.
American Journal of Epidemiology|September 19, 2007
History-adjusted marginal structural models for estimating time-varying effect modificationMaya L Petersen, Steven G Deeks, Jeffrey N Martin, et al.
JAMA|August 5, 2008
Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in AfricaElvin H Geng, Nneka Emenyonu, Mwebesa Bosco Bwana, et al.
Open Forum Infectious Diseases|August 7, 2023
Performance of Blood-Based Nucleocapsid Antigen Tests for Diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Infectious Viral Shedding: A Systematic ReviewSujata Mathur, Matthew So, Peggy Tahir, et al.
Human Immunology|January 4, 2012
Epistatic interactions between Fc (GM) and FcγR genes and the host control of human immunodeficiency virus replicationRaymond N Deepe, Emily Kistner-Griffin, Jeffrey N Martin, et al.
Pageof 36

Showing results (11-20 of 358) with videos related to

Sort By:
Pageof 36
AIDS (London, England)|September 9, 2004
Isolated lopinavir resistance after virological rebound of a ritonavir/lopinavir-based regimenJohn Friend, Neil Parkin, Teri Liegler, et al.
AIDS (London, England)|January 25, 2002
Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremiaSteven G Deeks, Jason D Barbour, Robert M Grant, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2009
Use of saliva as a lubricant in anal sexual practices among homosexual menLisa M Butler, Dennis H Osmond, Alison Graves Jones, et al.
Journal of Clinical Epidemiology|July 28, 2023
Key concepts in clinical epidemiology: collider-conditioning biasJean C Digitale, Jeffrey N Martin, David V Glidden, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2002
Effect of long-term highly active antiretroviral therapy in restoring HIV-induced abnormal B-lymphocyte functionMark A Jacobson, Hassan Khayam-Bashi, Jeffrey N Martin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
HIV-induced changes in T cell signaling pathwaysMarc Schweneker, David Favre, Jeffrey N Martin, et al.
American Journal of Epidemiology|September 19, 2007
History-adjusted marginal structural models for estimating time-varying effect modificationMaya L Petersen, Steven G Deeks, Jeffrey N Martin, et al.
JAMA|August 5, 2008
Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in AfricaElvin H Geng, Nneka Emenyonu, Mwebesa Bosco Bwana, et al.
Open Forum Infectious Diseases|August 7, 2023
Performance of Blood-Based Nucleocapsid Antigen Tests for Diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Infectious Viral Shedding: A Systematic ReviewSujata Mathur, Matthew So, Peggy Tahir, et al.
Human Immunology|January 4, 2012
Epistatic interactions between Fc (GM) and FcγR genes and the host control of human immunodeficiency virus replicationRaymond N Deepe, Emily Kistner-Griffin, Jeffrey N Martin, et al.
Pageof 36